Indication
Treatment of essential hypertension. This fixed dose combination is indicated in adult patients whose blood pressure is not adequately controlled on irbesartan or hydrochlorothiazide alone.
Loading your page…
Loading your page…
Hypertension
Marketing Authorisation Holder: Krka, d.d., Novo mesto
EMA Authorisation: 04/03/2011
INN: irbesartan;hydrochlorothiazide
AI Drug & Interaction Analysis
Free account required
Ask Osler about Ifirmacombi: drug interactions and guideline evidence, with every claim numbered to its source. For reference and learning, not treatment advice.
Medical disclaimer: This information is intended for qualified healthcare professionals. Always verify with the official EMA Summary of Product Characteristics (SmPC) before clinical use.